As current SRPs achieve their goals of becoming world-class and establishing the next generation of researchers, it is expected that other, high-potential research programmes will mature to become SRPs. Thus, all research programmes at NUHS would have the chance to become SRPs.
NUHS Summit Research Programmes
Cancer SRP
Focuses on cancer immunotherapy (cell-based, antibodies, and vaccines) and new cancer immunotherapy targets, finding ways to enhance the immune response, and developing and testing new therapies in clinical trials.
Cardiovascular Diseases SRP
Focuses on heart failure and coronary heart disease research using protein, microRNA and epigenetic markers, as well as developing new markers for novel diagnostics and treatments of these conditions.
DoHAD SRP
Launched in June 2009, the very detailed GUSTO birth cohort study aims to understand how pregnancy and early childhood conditions may affect later growth and development, as well as metabolic, neurodevelopmental and other disorders in Asia, and globally.
Metabolic Diseases SRP
Focuses on developing new diabetes therapies and establishing healthcare delivery models to enhance patient outcomes and improve physician adherence to best practices, and patient adherence to treatment.
Synthetic Biology SRP
Focuses on translational outcomes in various disease areas using synthetic biology tools such as microbial cell factories, therapeutic cells, synthetic bio-lixiviants, mammalian synthetic biology, biosensors, and synthetic genomes.
Tuberculosis (TB) SRP
Leverages access to the largest pool of TB cases worldwide and infrastructure to develop and deliver new TB treatments for patients. Researchers use novel drug screening techniques, animal models and imaging methods to find and test new drugs and novel treatment combinations.